Trevor Lowenthal
With emphasis on biotechnology, I focus my portfolio on undervalued opportunities. Through my position with Seeking Alpha, I hope to elucidate undervalued companies that are exploring revolutionary treatment modalities for a wide spectrum of rare and devastating medical conditions. I strive for an open, honest and insightful dialogue with expert and amateur readers alike. I appreciate your comments and encourage readers to follow me to stay updated on my newest stock ideas. I am happy to consider consulting opportunities, and is actively seeking a position as a healthcare analyst or writer.
Recent Articles by Trevor Lowenthal
HOW THE MOTLEY FOOL CAN HELP YOU
-
Premium Investing Guidance
Market beating stocks from our award-winning service
-
The Daily Upside Newsletter
Investment news and high-quality insights delivered straight to your inbox
-
Get Started Investing
You can do it. Successful investing in just a few steps
-
Win at Retirement
Secrets and strategies for the post-work life you want.
-
Find a Broker
Find the right brokerage account for you.
-
Listen to our Podcasts
Hear our experts take on stocks, the market, and how to invest.
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 04/16/2024.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.